Cargando…
Safety of N-Acetylcysteine at High Doses in Chronic Respiratory Diseases: A Review
N-Acetylcysteine (NAC) is widely used in respiratory medicine, with a maximum licensed dose in chronic use of 600 mg/day; however, some clinical trials have studied the efficacy of NAC at higher doses. The aim of this review was to evaluate the adverse effects profile of NAC at higher than the stand...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892733/ https://www.ncbi.nlm.nih.gov/pubmed/33326056 http://dx.doi.org/10.1007/s40264-020-01026-y |